Atherosclerosis Risk

Endothelial dysfunction weakens the artery lining’s normal protective role, allowing low-density lipoprotein cholesterol to enter the arterial wall. Once retained, the cholesterol can undergo oxidation, which promotes chronic inflammation and attracts immune cells. This sequence supports plaque growth and helps explain why vascular health, lipid levels, and inflammatory processes are central to cardiovascular risk assessment.

These conditions and exposures can promote the vascular and metabolic environment in which plaques develop. Hypertension is listed as a risk factor alongside smoking, diabetes, and dyslipidemia, meaning they contribute to a person’s overall clinical risk profile. Considering them together is important because risk assessment does not rely on a single measurement or isolated medical history item.

Age and family history are nonmodifiable factors that can increase atherosclerosis risk, even when a person can change other contributors. Their presence adds important context to lipid measurements, blood pressure, and medical history. Clinicians therefore interpret modifiable and nonmodifiable factors together rather than treating one favorable result as proof that overall cardiovascular risk is low.

Clinical assessment combines established risk factors with lipid measurements, blood pressure, and relevant medical history. The purpose is to form an integrated picture of cardiovascular risk rather than evaluate cholesterol or blood pressure alone. Depending on the clinical situation, imaging may also contribute additional information and help guide prevention decisions aimed at reducing future cardiovascular events.

Imaging may be considered when the available risk factors, laboratory measurements, blood pressure findings, and medical history do not provide the only information needed for clinical assessment. The overview identifies imaging as an occasional component rather than a universal requirement. Its role is to add information to the broader evaluation and support decisions about preventive management.

Recognizing modifiable contributors creates an opportunity to address them through lifestyle changes and treatments. In the clinical context, these interventions can slow plaque progression and reduce cardiovascular events, including heart attack and ischemic stroke. Prevention planning is therefore linked to the individual’s combined risk profile, rather than based solely on whether plaque-related disease is already apparent.